Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2

MLA

Norbert Stockhofe-Zurwieden, et al. “Assessment of Protective Efficacy of Live and Killed Vaccines Based on a Non-Encapsulated Mutant of Streptococcus Suis Serotype 2.” Veterinary Microbiology, vol. 84, no. 1–2, Dec. 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79585094d6ef993b7a916d8efd5a363d&authtype=sso&custid=ns315887.

APA

Norbert Stockhofe-Zurwieden, Hilde E. Smith, Luuk A.T Hilgers, & Henk J. Wisselink. (2001). Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2. Veterinary Microbiology, 84(1–2).

Chicago

Norbert Stockhofe-Zurwieden, Hilde E. Smith, Luuk A.T Hilgers, and Henk J. Wisselink. 2001. “Assessment of Protective Efficacy of Live and Killed Vaccines Based on a Non-Encapsulated Mutant of Streptococcus Suis Serotype 2.” Veterinary Microbiology 84 (1–2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79585094d6ef993b7a916d8efd5a363d&authtype=sso&custid=ns315887.